On February 26, 2026, the European Union published Directive (EU) 2026/470 on the simplification of the Corporate Sustainability Due Diligence Directive (“CSDDD”) and the Corporate Sustainability Reporting Directive (“CSRD”) in its Official Journal, clearing the final step in the Omnibus I legislative process.

This blog post: (i) summarizes the substance of the final agreement on certain key provisions that were heavily negotiated for the CSDDD and CSRD; and (ii) explains the timelines for Member State transposition, upcoming delegated and implementing rules, and other key mandated Commission steps, including publication of Commission guidelines and model contract clauses.

The two key pieces of imminent Commission action for companies to track are likely: for CSRD, the final adoption of the European Sustainability Reporting Standards (“ESRS”) in Q2 this year; and for CSDDD, the Commission’s adoption of the first CSDDD Guidelines statutorily required by July 2027. The CSDDD Guidelines will be particularly important because they will provide more concrete guidance on operationalizing CSDDD compliance.

CSDDD – Final Applicability Thresholds & Timing

  • Applicability Thresholds:
    • For EU-incorporated companies: 5,000+ employees and over EUR 1.5 billion in net worldwide turnover (on a consolidated basis for EU ultimate parent companies of corporate groups).
    • For non-EU incorporated companies: EUR 1.5 billion in net turnover generated in the EU (on a consolidated basis for non-EU ultimate parent companies of corporate groups).
  • Timing:
    • Transposition: Member States’ CSDDD transposition deadline has been pushed to July 26, 2028 (one year before CSDDD application starts).
    • Application: In-scope companies must comply by July 26, 2029. The new amending Directive aligns all in-scope companies on a single 2029 application date (as opposed to the staggered application dates set out in the original CSDDD).
  • Level of Harmonization: To reduce fragmentation and legal uncertainty, the final agreement further expands the harmonization requirement for Member States as they transpose CSDDD into national law. Harmonization now also covers the CSDDD obligations related to prioritization, monitoring due diligence measures, and reporting.  However, the revised harmonization clause still leaves room for Member States to adopt additional due diligence obligations concerning specific products, services, or situations where the Member State seeks to achieve a different level of protection.  Monitoring Member State transposition will therefore continue to be important.
  • Changes to Due Diligence Obligations: The amended CSDDD preserves and further defines a risk-based approach to identifying and assessing adverse impacts across a company’s broader value chain. This includes all business partners within the “chain of activities,” rejecting proposals that would have fundamentally distinguished between direct and indirect partners. Key elements include:
    • Risk Factors: When taking appropriate measures to identify and assess adverse impacts, companies must consider relevant risk factors. The CSDDD now provides a non-exhaustive list of these relevant risk factors, including:
      • Whether business partners fall outside the scope of the CSDDD or are not covered by comparable mandatory sustainability due diligence laws;
      • Geography and context, such as the level of law enforcement with respect to specific adverse impact types; and
      • The context of the sector, level of business operations, and product or service in question.
    • Risk Identification and Assessment Steps: Article 8 was the most heavily negotiated of the substantive due diligence obligations and now works as follows:
      • Step One – Scoping Exercise: Companies must first carry out a “scoping exercise” based solely on reasonably available information, where the in-scope company must identify general areas across its own operations, those of its subsidiaries, and, where related to its chain of activities, those of its business partners where adverse impacts are most likely to occur and to be most severe.
      • Step Two – In-Depth Assessment: Based on the results of their scoping exercise, companies must then carry out an in-depth assessment in the areas where adverse impacts were identified to be most likely to occur and most severe. Where adverse impacts are identified as equally likely to occur or equally severe in several areas, companies may prioritize assessing such areas which involve direct business partners.
    • Value Chain Information Cap: For in-depth assessments in “Step Two” above, companies must only seek information from business partners where necessary and, for business partners with fewer than 5,000 employees, only when the information cannot reasonably be obtained by other means.
    • Prevention and Remediation: In-scope companies are no longer required to terminate, as a last resort, their business relationships with business partners where adverse impacts have arisen, though complex suspension rules will still apply. If there is a “reasonable expectation” that a company’s enhanced prevention or corrective action plan will succeed, the mere fact of continuing to engage with the specific business partner will not expose the company to penalties or civil liability.
    • Stakeholder Engagement: While the amended CSDDD narrows the definition of “stakeholders” (for example, consumers are no longer in scope), the definition of stakeholders with which companies must engage within the context of various due diligence obligations remains fairly broad. The circumstances in which relevant stakeholder engagement must be undertaken has been narrowed. For example, consultation is no longer required when deciding to suspend business relationships.
  • Deletion of Climate Transition Plans: The amended CSDDD fully deletes the requirement to adopt or “put into effect” climate transition plans. However, the ESRS provisions on reporting climate transition plans are poised to be maintained, meaning companies that have such plans must continue to report on them under the CSRD in line with the ESRS.
  • Civil Liability: The final agreement removes the mandatory EU-wide civil liability regime. Civil liability for CSDDD breaches remains subject to each Member State’s national rules and court procedures. However, Article 36 of the CSDDD provides for a review clause to assess the effectiveness of existing enforcement mechanisms by July 2031, and every five years thereafter, and, where appropriate, to accompany that review with a legislative proposal. This means that an EU-wide civil liability framework could be revisited in the future.
  • Penalties: The Commission is responsible for issuing penalty-setting guidelines to assist supervisory authorities in determining the level of penalties in accordance with the CSDDD obligation that has been violated. While this guidance will instruct the CSDDD’s Supervisory Authority Network, Member States must ensure that the maximum cap of pecuniary penalties is set at 3% of a company’s net worldwide turnover (or for third-country ultimate parent companies, 3% of the net consolidated worldwide turnover calculated at the ultimate parent level).
  • Forthcoming Commission Guidelines: The Commission must adopt extensive CSDDD implementation guidance that will directly shape compliance expectations, with materials due in various phases:
    • By July 26, 2027: Guidelines on due diligence processes (including risk identification and prioritization, appropriate measures, and responsible disengagement), stakeholder engagement, available data sources, and digital tools and technologies. The Commission must also provide guidelines on model contractual clauses and guidance on the assessment of relevant risk factors at various levels.
    • By July 26, 2028: Guidelines on resource- and information-sharing in line with trade-secret protection, protection from retaliation and retribution, and guidance for stakeholders engaging throughout the due diligence process.
    • By March 31, 2029: The Commission shall adopt delegated acts setting forth the content and criteria for companies that publish annual website statements under the CSDDD reporting obligation because they are not exempted by virtue of their CSRD reporting.

CSRD – Final Applicability Thresholds & Timing

  • Applicability Thresholds:
    • For EU companies: 1,000+ employees and a net turnover of EUR 450 million, with numbers consolidated for EU-incorporated (intermediate) parent companies. For EU companies, reporting starts for FYs that begin in 2027 (with reports due in 2028/29).
    • For non-EU ultimate parent companies: Third-country ultimate parent companies generating EUR 450 million net turnover within the EU, with an EU subsidiary or branch that has more than EUR 200 million in net turnover. For these companies, reporting starts for FYs beginning in 2028 (with reports due in 2029/30).
    • Exemption for certain financial holding companies: The final agreement exempts from direct reporting requirements “financial holding” companies that have the sole purpose of acquiring and managing shares in other companies, without directly or indirectly being involved in the management of those companies. The subsidiaries of those companies may have reporting requirements, if they meet the applicability requirements in their own right.
    • Transition relief: Member States have the option to exempt “Wave 1” companies required to report under the CSRD from reporting in FY 2025 and FY 2026.
  • Timing:
    • Member States have until March 19, 2027, to transpose the CSRD and Audit Directive changes.
  • Audit and Assurance: While reasonable assurance of sustainability reports is no longer required, limited assurance requirements are maintained. The Commission is required to adopt harmonized limited assurance standards by July 1, 2027, to allow adequate time to develop these standards. Additionally, the Audit Directive introduces simplified auditor registration requirements for a transitional period from 2025 to 2030, and an exemption from supervision for third-country auditors and audit entities issuing assurance reports.
  • ESRS (“European Sustainability Reporting Standards”): The Commission is tasked with formally adopting revised and streamlined ESRS in a delegated act within six months after entry into force of the amended CSRD. On December 3, 2025, the European Financial Reporting Advisory Group (“EFRAG”) sent the Commission its technical advice on draft simplified ESRS. EFRAG’s guidance preserves the CSRD’s distinct double materiality assessment (albeit streamlined), reduces the total number of data points, introduces flexibility for data collection and the use of estimates, increases interoperability, and introduces the option of a top-down approach to materiality assessments. The Commission is not required to follow EFRAG’s technical advice, but we expect it will closely follow it.
  • Value Chain Information Cap: Companies reporting under the CSRD are not allowed to request information from companies with an average of less than 1,000 employees, beyond what is required under the voluntary reporting standard for non-listed micro, small and medium enterprises (“VSME”). This cap will only apply to information requests for CSRD reporting purposes, and not to other commercial information exchanges. Within 4 months of this Directive entering into force, the Commission will adopt a delegated act providing voluntary reporting standards for undertakings protected by the information value chain cap.
  • Taxonomy Reporting: As in the current CSRD, only companies within the proposed scope of CSRD reporting will be required to report under Article 8 of the Taxonomy Regulation. The Commission’s proposed option to report on partial Taxonomy alignment was deleted from the final text.

* * *

If you have any questions concerning the material discussed in this post, please contact the members of our Sustainability/Environmental, Social, and Governance (ESG) practice.

This blog post was written with the contributions of Pol Revert Loosveldt.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Zoé Bertrand Zoé Bertrand

Zoé Bertrand is an associate in the Sustainability and Life Sciences Practice Groups, where her practice covers ESG, sustainability, environmental, food, and pharmaceutical regulation. She has experience in a wide range of regulatory and compliance issues with a focus on EU, Belgian, and…

Zoé Bertrand is an associate in the Sustainability and Life Sciences Practice Groups, where her practice covers ESG, sustainability, environmental, food, and pharmaceutical regulation. She has experience in a wide range of regulatory and compliance issues with a focus on EU, Belgian, and French regulatory advice.

She advises on compliance with EU ESG regulations, encompassing the CSRD, the CSDDD, and the EUDR, covering aspects as scope, timeline, implementation, and enforcement. As part of her practice, Zoé also covers environmental matters including the urban wastewater treatment directive, extended producer responsibility, chemicals regulations, and greenwashing.

Zoé also assists clients with the implementation of the Nagoya Protocol and the access and benefit sharing rules of a number of jurisdictions. Zoé closely follows international developments on biodiversity.

Photo of Hannah Edmonds-Camara Hannah Edmonds-Camara

Hannah is a founding member of the firm’s Business and Human Rights (BHR) practice and advises on a breadth of BHR and ESG issues. In particular, Hannah has deep experience advising on the development and implementation of global human rights and environmental due…

Hannah is a founding member of the firm’s Business and Human Rights (BHR) practice and advises on a breadth of BHR and ESG issues. In particular, Hannah has deep experience advising on the development and implementation of global human rights and environmental due diligence programmes, in response to the evolving, global regulatory landscape.

She advises on: compliance with ESG disclosure and due diligence requirements, including the EU’s CSRD and CSDDD; BHR-related investigations and remediation strategies; responding to complaints raised through non-judicial grievance mechanisms (including OECD National Contact Points); ESG due diligence in an M&A context; global risk assessments; workplace culture reviews; design of project and issue-specific human rights frameworks and stakeholder engagement strategies; and policy engagement on BHR legislative files.

Photo of Daniel Feldman Daniel Feldman

Dan Feldman co-chairs the firm’s ESG and Business & Human Rights practices.

Drawing on his prior positions in government service spanning multiple Administrations, former Ambassador Dan Feldman’s practice focuses on environmental, social, and governance (ESG) counseling, business and human rights (BHR), global public…

Dan Feldman co-chairs the firm’s ESG and Business & Human Rights practices.

Drawing on his prior positions in government service spanning multiple Administrations, former Ambassador Dan Feldman’s practice focuses on environmental, social, and governance (ESG) counseling, business and human rights (BHR), global public policy, as well as broader international regulatory compliance. He is a member of the firm’s Global Problem Solving initiative.

As Chief of Staff and Counselor to Secretary John Kerry when he was appointed the first Special Presidential Envoy for Climate (SPEC) by President Biden, Dan helped drive the U.S. government’s international climate agenda, coordinating high level interagency policy-making, engaging with corporate stakeholders, and contributing to key bilateral and multilateral climate discussions, including the 2021 Leaders’ Summit on Climate and the landmark UN Conference of Parties (COP26) in Glasgow.

Previously, Dan served as deputy and then U.S. Special Representative for Afghanistan and Pakistan at the U.S. Department of State in the Obama Administration, as Director of Multilateral and Humanitarian Affairs at the National Security Council in the Clinton Administration, and as Counsel and Communications Adviser to the U.S. Senate Homeland Security and Governmental Affairs Committee. He also has served as a senior foreign policy and national security advisor to a number of Democratic presidential and Congressional campaigns.

Dan has extensive experience counseling multinational corporations on mitigating risk and maximizing opportunities in the development and implementation of their ESG and sustainability strategies, with a particular background in advising on BHR matters. He was one of the first attorneys in the U.S. to develop a practice in corporate social responsibility, and has been cited by Chambers for his BHR expertise. He assists clients in strategizing about their engagements with a range of key stakeholders, including Members of Congress, executive branch officials, foreign government officials and Embassy representatives, multilateral institutions, trade and industry associations, non-governmental organizations, opinion leaders, and journalists.

Photo of Seán Finan Seán Finan

Seán Finan is an associate in the Life Sciences team. His practice covers environmental, food and beverage and pharmaceutical regulation.

Seán has specific experience in a number of key areas for EU and UK clients in the technology, food and beverage, pharmaceutical, cosmetic…

Seán Finan is an associate in the Life Sciences team. His practice covers environmental, food and beverage and pharmaceutical regulation.

Seán has specific experience in a number of key areas for EU and UK clients in the technology, food and beverage, pharmaceutical, cosmetic and consumer goods industries, including:

Environmental and ESG compliance issues, including CSRD, CSDDD and green taxonomy issues; green public procurement issues; extended producer responsibility obligations, etc.;
Advertising claims, particularly environmental claims and greenwashing;
General food regulation; novel food regulation; genetically modified and “precision bred” products; and
Chemicals legislation (REACH, CLP, biocides, etc.).

Seán has represented clients in judicial review actions involving novel foods against multiple national regulators.

Seán is qualified in both England & Wales, and the Republic of Ireland.

Seán is a co lead of the firm’s Disability and Mental Health affinity group.

Photo of Cándido García Molyneux Cándido García Molyneux

Cándido García Molyneux provides clients with regulatory, policy and strategic advice on EU environmental and product safety legislation. He helps clients influence EU legislation and guidance and comply with requirements in an efficient manner, representing them before the EU Courts and institutions.

Cándido…

Cándido García Molyneux provides clients with regulatory, policy and strategic advice on EU environmental and product safety legislation. He helps clients influence EU legislation and guidance and comply with requirements in an efficient manner, representing them before the EU Courts and institutions.

Cándido co-chairs the firm’s Environmental Practice Group.

Cándido has a deep knowledge of EU requirements on chemicals, circular economy and waste management, climate change, energy efficiency, renewable energies as well as their interrelationship with specific product categories and industries, such as electronics, cosmetics, healthcare products, and more general consumer products. He has worked on energy consumption and energy efficiency requirements of AI models under the EU AI Act.

In addition, Cándido has particular expertise on EU institutional and trade law, and the import of food products into the EU. Cándido also regularly advises clients on Spanish food and drug law.

Cándido is described by Chambers Europe as being “creative and frighteningly smart.” His clients note that “he has a very measured, considered, deliberative manner,” and that “he has superb analytical and writing skills.”

Photo of Elise Hartnett Elise Hartnett

Elise Hartnett advises clients on EU and U.S. regulatory and policy matters across environmental, social, and governance (ESG), business and human rights (BHR), international trade, and public policy.

Her practice includes providing clients with tailored advice on EU sustainability laws, global supply chain…

Elise Hartnett advises clients on EU and U.S. regulatory and policy matters across environmental, social, and governance (ESG), business and human rights (BHR), international trade, and public policy.

Her practice includes providing clients with tailored advice on EU sustainability laws, global supply chain due diligence, human rights and environmental policy development, evolving greenhouse gas and corporate climate action reporting requirements, and navigating compliance risks under EU and international legal obligations.

Elise also maintains an active pro bono practice focused on media freedom, human rights, and access to justice.

Photo of Max Jerman Max Jerman

Max Jerman is an associate in the Life Sciences Practice group. Max advises clients across a wide range of regulatory and compliance issues in the pharmaceutical, food, and cosmetics sectors, with a focus on EU and Italian regulatory advice. He is a native…

Max Jerman is an associate in the Life Sciences Practice group. Max advises clients across a wide range of regulatory and compliance issues in the pharmaceutical, food, and cosmetics sectors, with a focus on EU and Italian regulatory advice. He is a native Italian and Slovenian speaker.

Photo of Lasse Luecke Lasse Luecke

Lasse Luecke advises clients on EU regulatory and policy matters with a focus on environmental, technology, and product safety legislation. He has particular expertise in radio equipment legislation, including radiofrequency spectrum use and availability, data center regulation, and sustainability reporting frameworks, where he…

Lasse Luecke advises clients on EU regulatory and policy matters with a focus on environmental, technology, and product safety legislation. He has particular expertise in radio equipment legislation, including radiofrequency spectrum use and availability, data center regulation, and sustainability reporting frameworks, where he supports companies in meeting complex and rapidly evolving compliance obligations. Lasse also helps clients anticipate legislative developments, shape regulatory strategy, and engage constructively with EU institutions and policymakers.

Photo of Paul Mertenskötter Paul Mertenskötter

Paul Mertenskötter advises companies, investors, and governments on regulatory sustainability, international trade, and public policy matters.

Paul has particular experience advising multinational companies on EU sustainability laws, including the Corporate Sustainability Reporting Directive (CSRD), the Corporate Sustainability Due Diligence Directive (CSDDD), the Taxonomy…

Paul Mertenskötter advises companies, investors, and governments on regulatory sustainability, international trade, and public policy matters.

Paul has particular experience advising multinational companies on EU sustainability laws, including the Corporate Sustainability Reporting Directive (CSRD), the Corporate Sustainability Due Diligence Directive (CSDDD), the Taxonomy Regulation, the Forced Labor Regulation, and the Carbon Border Adjustment Mechanism (CBAM). His practice also spans a wide range of climate change issues, including carbon offsets, accounting rules, and related international sustainability reporting frameworks such as the International Sustainability Standards Board (ISSB). Paul further advises clients on their strategic engagement with the rules of the World Trade Organization (WTO), free trade agreements, the Paris Agreement, and general public international law.

Prior to joining the firm, Paul was a Visiting Scholar at the WTO in Geneva, clerked at the International Court of Justice in The Hague, and was a Fellow at the Institute for International Law and Justice at NYU Law School.

Photo of Tom Plotkin Tom Plotkin

Tom Plotkin advises companies on a broad range of ESG and sustainability issues with a focus on social responsibility, including business and human rights, equity and civil rights, and external engagement and brand reputation.

As a member of Covington’s Business and Human Rights…

Tom Plotkin advises companies on a broad range of ESG and sustainability issues with a focus on social responsibility, including business and human rights, equity and civil rights, and external engagement and brand reputation.

As a member of Covington’s Business and Human Rights practice, Tom advises clients on all aspects of the corporate responsibility to respect human rights, including issues related to supply chain due diligence and responsible sourcing, downstream product use and human rights impacts, and strategies for integrating human rights oversight into broader compliance programs.

Tom is also a member of Covington’s Institutional Culture and Social Responsibility practice, where he assists companies in evaluating and managing the legal, business, and reputational risks associated with social impacts of business practices. Tom’s work in this area focuses on civil rights and diversity, equity, and inclusion.

As a member of Covington’s Sustainability practice, Tom draws on his social responsibility portfolio to assist companies in bridging internal practices and external engagement strategies. Tom assists with public ESG reporting, responding to shareholder ESG proposals, and external stakeholder engagement.

Tom is also a member of Covington’s Employment practice, where he advises on a range of domestic and international employment law issues.

Photo of Emma Sawatzky Emma Sawatzky

Emma Sawatzky advises clients on a range of human rights and sustainability issues and supports them in evaluating and addressing potential legal, operational, and reputational risks across geographies and sectors.

As a member of Covington’s Business and Human Rights and Sustainability Practice Groups…

Emma Sawatzky advises clients on a range of human rights and sustainability issues and supports them in evaluating and addressing potential legal, operational, and reputational risks across geographies and sectors.

As a member of Covington’s Business and Human Rights and Sustainability Practice Groups, Emma advises clients on the rapidly evolving legal and enforcement landscape. Emma has experience with preparing clients for modern slavery and sustainability reporting; conducting gap assessments and developing action plans for sophisticated compliance programs; formulating human rights policies; conducting BHR-related investigations and implementing remediation strategies; advising on human rights-related OECD proceedings; developing responsible sourcing frameworks (including risk assessments, traceability exercises, and supplier engagement strategies); and advising on the potential human rights impacts of downstream product and service use. Emma also assists clients with white collar investigations.

Photo of Pimara Soongswang Pimara Soongswang

Pimmy Soongswang is an associate in the Business and Human Rights (BHR) and Sustainability practice groups. She advises clients on their human rights obligations under international standards and supports them in navigating the evolving legal frameworks surrounding responsible business conduct.

Pimmy works across…

Pimmy Soongswang is an associate in the Business and Human Rights (BHR) and Sustainability practice groups. She advises clients on their human rights obligations under international standards and supports them in navigating the evolving legal frameworks surrounding responsible business conduct.

Pimmy works across a range of BHR-related matters, including global supply chain due diligence, modern slavery reporting, forced labour-related import bans, human rights policy development, and OECD proceedings involving human rights issues. Her practice also includes assessing downstream human rights risks associated with AI and other digital products within the context of developing human rights due diligence frameworks.

Pimmy is engaged in pro bono work focused on the rights of women and underrepresented communities. In addition to her client work, she contributes to the firm’s diversity and inclusion efforts

Photo of Bart Van Vooren Bart Van Vooren

Bart Van Vooren, partner leads a dynamic practice at the intersection of EU regulatory law, global health, and biodiversity law. In these fields, he advises innovative pharmaceutical, food, cosmetic and technology companies on complex EU and global regulatory, compliance and policy assignments.

Bart…

Bart Van Vooren, partner leads a dynamic practice at the intersection of EU regulatory law, global health, and biodiversity law. In these fields, he advises innovative pharmaceutical, food, cosmetic and technology companies on complex EU and global regulatory, compliance and policy assignments.

Bart holds a Ph.D. in EU and International Law and was a professor of EU law until 2013. During that time, he wrote the first-ever handbook with Cambridge University Press on “EU External Relations Law” (2014). He then transitioned to private practice, and frequently acted for the Belgian government before the EU Court of Justice (e.g. C-16/16P Belgium vs Commission). Bart joined Covington in 2016, leading some of our most consequential EU litigation proceedings (e.g. C-311/18 “Schrems II”) over the years.  Having handled nearly 50 cases before the EU Court, he’s uniquely qualified to support our corporate clients in our most high-stakes disputes. Recent examples include T-189/21 Aloe Vera of Europe v Commission (which we won, so the Commission decided to appeal); as well as T-201/21 Covington & Burling and Van Vooren v Commission (which we also won, and hence is also on appeal).

As a pioneer in biodiversity law, over the past 15 years Bart has built a unique, global practice on Access and Benefit-Sharing (ABS) laws under the Convention on Biological Diversity, the Nagoya Protocol, the Plant Treaty, the High Seas Treaty and the WHO Pandemic Agreement. ABS compliance is critical when sourcing biological materials for life sciences R&D and I work with many of the world’s innovative life sciences companies on the whole range of e.g. transactional, contractual, compliance, IP, (EU) regulatory and litigation work relating to ABS. As biodiversity has increasingly become identified as a major commercial and financial risk to companies, so has the practice expanded to e.g. biodiversity credit markets, biodiversity insurance, biodiversity claims and advertising, and so on. Since April 2025, Bart has been appointed as the industry representative to the Steering Committee of the UN Biodiversity Fund that seeks funding from the private sector for biodiversity conservation and restoration.

Bart also pioneered our global health practice. He has advised pharmaceutical clients on seasonal and pandemic influenza since 2016. Since then, this practice area expanded to cover all matters relating to infectious diseases, and as of 2020, emergency preparedness and response (eg. WHO prequalification, International Coordination Group negotiations, Emergency Use Listing, International Health Regulations Rev 2024). He has been the pharmaceutical industry’s lead lawyer advising on the WHO Pandemic Treaty negotiations, adopted on 14 May 2025. Currently, he continues to advise on the work of the Intergovernmental Working Group (“IGWG”) teasing out the technical details of the “Pathogen Access and Benefit-Sharing System” intended to create legally binding obligations on companies to commit vaccines, therapeutics and diagnostics in case of a new global health emergency.

In Chambers rankings, clients have kindly described Bart as “very knowledgeable, action-focused and service-focused lawyer”, adding that he “really tries to find a way of working through challenges”, am “customer-oriented” and provide “sound advice and reasonable options for our business with pros and cons.”

Finally, Bart has an active pro bono practice assisting NGOs defending the human rights of persons with a disability through strategic litigation before the EU Court.